Naturally Independent Expo
CapsCanada

Click Here for the Latest Episode of the Vitamin Professor Podcast Hosted by Gene Bruno

Lipogen Builds Phospholipids R&D Center

by Shari Barbanel | November 19, 2015

Lipogen Builds Phospholipids R&D center (2)

Lipogen Ltd. (Haifa, Israel) is expanding its production facilities and building a new phospholipids research and development center in response to a rapid  jump in sales of brain and stress health solutions in Q1-Q3 2015.

Lipogen invested $2.6 million (U.S.) in building two additional production lines for PhosphatidylSerine (PS) and Phosphatidic Acid (PA). The company also added 10,000 square feet to its facilities to double production capabilities for PS and PA. Upgrades include automated controlled processing to reduce production costs through improved production traceability, and implementing new safety methods, allowing Lipogen to produce its all-natural, non-GMO (genetically modified organism), solvent-free ingredients in accordance with the highest industry standards.

Lipogen drive innovation strategy of new phospholipid solutions

“Increasing demand for our brain health and stress management ingredients pushed us to establish a new growth strategy for our PS and PA product line,” said David Rutenberg, CEO of Lipogen. “The phospholipids market is expanding from traditional brain function support to new brain health concepts, including: stress management, cortisol control, ADHD mitigation, sports nutrition and more.”

Lipogen continues to research and develop new cognitive and stress management solutions based on proprietary technology and enzymatic process. The advanced, well-equipped phospholipids R&D center was designed to support product development and product research at Lipogen facilities. The company has appointed Abraham Rutenberg as vice president and R&D manager. In addition, Lipogen expanded its headquarters, appointing Ariel Gordon as vice president business development manager to develop new segments and markets for Lipogen’s leading brands.

“I’m excited to welcome Abraham Rutenberg and Ariel Gordon to our team,” said Rutenberg. “They will lead Lipogen to the next level via high-impact growth—not only in the dietary supplements industry, but also in the food, beverage and pharmaceuticals industries. Lipogen is committed to producing pure, high-quality products with minimal damage to the environment. We’ve initiated a long-term sustainability strategy for our complete product line.”

For more information, visit www.lipogenbio.com.

Don't Miss Out!

Sign up for Nutrition Industry Executive Digital Newsletter
Digital Newsletter
Subscribe to Nutrition Industry Executive Magazine
Nutrition Industry Executive Magazine

Industry Professionals
Stay Informed!

Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.

Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.

Featured Listings:


CapsCanada

Subscribe To Our Newsletter

Stay Informed! Breaking news, industry trends featured topics, and more.

Subscribe to our newsletter today!